Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

Circulation

Volumn 104, Issue 25, 2001, Pages 3052-3056

  Wallace, A Michael ^a   McMahon, Alex D ^a   Packard, Chris J ^a   Kelly, Anne ^a   Shepherd, James ^a   Gaw, Allan ^a   Sattar, Naveed ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adipocytes; Cardiovascular diseases; Inflammation; Insulin resistance

Indexed keywords

C REACTIVE PROTEIN; LEPTIN;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

EID: 0035909997     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc5001.101061     Document Type: Article

References (28)

1. Leptin: The tale of an obesity gene
2. Adipose tissue as an endocrine and paracrine organ
3. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro
4. Insulin and cortisol promote leptin production in cultured human fat cells
5. Plasma leptin and insulin relationships in obese and nonobese humans
6. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men
7. Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius: Mauritius NCD Study Group
8. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?
9. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women
10. Sensitive C-reactive protein and basal endothelial function
11. Increased plasma leptin levels are associated with fat accumulation in Japanese Americans
12. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans
13. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group
14. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coronary Prevention Study Group
15. Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study
16. Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study
17. Differences in circulating concentrations of total, free and bound leptin relate to gender and body composition in adults humans
18. Leptin is associated with increased risk of myocardial infarction
19. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort
20. Leptinemia is not a risk factor for ischemic heart disease in men: Prospective results from the Quebec Cardiovascular Study
21. Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus
22. Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/insulin ratio in non-diabetic subjects
23. Etiology of the metabolic syndrome: Potential role of insulin resistance, leptin resistance, and other players
24. Reducing the burden of diabetes: Managing cardiovascular disease
25. The coordinated cytokine/hormone response to acute injury incorporates leptin
26. Chronic subclinical inflammation as part of the insulin resistance syndrome: The Insulin Resistance Atherosclerosis Study (IRAS)
27. Pravastatin and the development of diabetes mellitus: Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
28. Effect of long-term changes in diet and exercise on plasma leptin concentrations